Copyright Reports & Markets. All rights reserved.

China Finasteride Market Report 2018

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Finasteride Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Type I Market Performance (Volume)
      • 2.1.2 Type II Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.1.1 Type I Market Performance (Value)
      • 2.1.2 Type II Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Benign Prostatic Hyperplasia Market Performance (Volume)
      • 3.1.2 Male Pattern Baldness Market Performance (Volume)
      • 3.1.3 Other Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Merck
      • 4.1.1 Merck Profiles
      • 4.1.2 Merck Product Information
      • 4.1.3 Merck Finasteride Business Performance
      • 4.1.4 Merck Finasteride Business Development and Market Status
    • 4.2 Actavis
      • 4.2.1 Actavis Profiles
      • 4.2.2 Actavis Product Information
      • 4.2.3 Actavis Finasteride Business Performance
      • 4.2.4 Actavis Finasteride Business Development and Market Status
    • 4.3 Sandoz
      • 4.3.1 Sandoz Profiles
      • 4.3.2 Sandoz Product Information
      • 4.3.3 Sandoz Finasteride Business Performance
      • 4.3.4 Sandoz Finasteride Business Development and Market Status
    • 4.4 Teva Pharmaceuticals
      • 4.4.1 Teva Pharmaceuticals Profiles
      • 4.4.2 Teva Pharmaceuticals Product Information
      • 4.4.3 Teva Pharmaceuticals Finasteride Business Performance
      • 4.4.4 Teva Pharmaceuticals Finasteride Business Development and Market Status
    • 4.5 Cipla
      • 4.5.1 Cipla Profiles
      • 4.5.2 Cipla Product Information
      • 4.5.3 Cipla Finasteride Business Performance
      • 4.5.4 Cipla Finasteride Business Development and Market Status
    • 4.6 RelonChem
      • 4.6.1 RelonChem Profiles
      • 4.6.2 RelonChem Product Information
      • 4.6.3 RelonChem Finasteride Business Performance
      • 4.6.4 RelonChem Finasteride Business Development and Market Status
    • 4.7 Dr. Reddy
      • 4.7.1 Dr. Reddy Profiles
      • 4.7.2 Dr. Reddy Product Information
      • 4.7.3 Dr. Reddy Finasteride Business Performance
      • 4.7.4 Dr. Reddy Finasteride Business Development and Market Status
    • 4.8 Accord Pharmaceuticals
      • 4.8.1 Accord Pharmaceuticals Profiles
      • 4.8.2 Accord Pharmaceuticals Product Information
      • 4.8.3 Accord Pharmaceuticals Finasteride Business Performance
      • 4.8.4 Accord Pharmaceuticals Finasteride Business Development and Market Status
    • 4.9 Henan Topfond
      • 4.9.1 Henan Topfond Profiles
      • 4.9.2 Henan Topfond Product Information
      • 4.9.3 Henan Topfond Finasteride Business Performance
      • 4.9.4 Henan Topfond Finasteride Business Development and Market Status
    • 4.10 Zhejiang CONBA Pharmaceutical
      • 4.10.1 Zhejiang CONBA Pharmaceutical Profiles
      • 4.10.2 Zhejiang CONBA Pharmaceutical Product Information
      • 4.10.3 Zhejiang CONBA Pharmaceutical Finasteride Business Performance
      • 4.10.4 Zhejiang CONBA Pharmaceutical Finasteride Business Development and Market Status
    • 4.11 Shandong Renhetang Pharmaceutical
    • 4.12 Guangdong Eashu Pharmacetical

    5 Market Performance for Manufacturers

    • 5.1 China Finasteride Sales (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 China Finasteride Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 China Finasteride Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 China Finasteride Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 South China Market Performance for Manufacturers
      • 6.1.1 South China Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.1.2 South China Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.1.3 South China Finasteride Price (USD/Unit) of Manufacturers 2013-2018
      • 6.1.4 South China Finasteride Gross Margin of Manufacturers 2013-2018
      • 6.1.5 Market Concentration
    • 6.2 East China Market Performance for Manufacturers
      • 6.2.1 East China Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.2.2 East China Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.2.3 East China Finasteride Price (USD/Unit) of Manufacturers 2013-2018
      • 6.2.4 East China Finasteride Gross Margin of Manufacturers 2013-2018
      • 6.2.5 Market Concentration
    • 6.3 Southwest China Market Performance for Manufacturers
      • 6.3.1 Southwest China Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.3.2 Southwest China Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.3.3 Southwest China Finasteride Price (USD/Unit) of Manufacturers 2013-2018
      • 6.3.4 Southwest China Finasteride Gross Margin of Manufacturers 2013-2018
      • 6.3.5 Market Concentration
    • 6.4 Northeast China Market Performance for Manufacturers
      • 6.4.1 Northeast China Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.4.2 Northeast China Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.4.3 Northeast China Finasteride Price (USD/Unit) of Manufacturers 2013-2018
      • 6.4.4 Northeast China Finasteride Gross Margin of Manufacturers 2013-2018
      • 6.4.5 Market Concentration
    • 6.5 North China Market Performance for Manufacturers
      • 6.5.1 North China Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.5.2 North China Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.5.3 North China Finasteride Price (USD/Unit) of Manufacturers 2013-2018
      • 6.5.4 North China Finasteride Gross Margin of Manufacturers 2013-2018
      • 6.5.5 Market Concentration
    • 6.6 Central China Market Performance for Manufacturers
      • 6.6.1 Central China Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.6.2 Central China Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.6.3 Central China Finasteride Price (USD/Unit) of Manufacturers 2013-2018
      • 6.6.4 Central China Finasteride Gross Margin of Manufacturers 2013-2018
      • 6.6.5 Market Concentration
    • 6.7 Northwest China Market Performance for Manufacturers
      • 6.7.1 Northwest China Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.7.2 Northwest China Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.7.3 Northwest China Finasteride Price (USD/Unit) of Manufacturers 2013-2018
      • 6.7.4 Northwest China Finasteride Gross Margin of Manufacturers 2013-2018
      • 6.7.5 Market Concentration

    7 China Finasteride Market Performance (Sales Point)

    • 7.1 China Finasteride Sales (K Units) and Market Share by Regions 2013-2018
    • 7.2 China Finasteride Revenue (M USD) and Market Share by Regions 2013-2018
    • 7.3 China Finasteride Price (USD/Unit) by Regions 2013-2018
    • 7.4 China Finasteride Gross Margin by Regions 2013-2018

    8 Development Trend for Regions (Sales Point)

    • 8.1 China Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.2 South China Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.3 East China Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.4 Southwest China Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.5 Northeast China Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.6 North China Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.7 Central China Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Northwest China Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Benign Prostatic Hyperplasia Industry
    • 11.2 Male Pattern Baldness Industry
    • 11.3 Other Industry

    12 Market Forecast 2019-2024

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 12.1.1 China Finasteride Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 12.1.2 China Finasteride Sales (K Units) and Growth Rate 2019-2024
      • 12.1.3 South China Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.4 East China Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.5 Southwest China Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.6 Northeast China Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.7 North China Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.8 Central China Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.9 Northwest China Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
      • 12.3.1 Overall Market Performance
      • 12.3.2 Type I Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.3 Type II Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.4 Sales by Application 2019-2024
      • 12.4.1 Overall Market Performance
      • 12.4.2 Benign Prostatic Hyperplasia Sales and and Growth Rate 2019-2024
      • 12.4.3 Male Pattern Baldness Sales and and Growth Rate 2019-2024
      • 12.4.4 Other Sales and and Growth Rate 2019-2024
    • 12.5 Price (USD/Unit) and Gross Profit
      • 12.5.1 China Finasteride Price (USD/Unit) Trend 2019-2024
      • 12.5.2 China Finasteride Gross Profit Trend 2019-2024

    13 Conclusion

    Geographically, this report split China into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Finasteride for these regions, from 2012 to 2023 (forecast), including
    South China
    East China
    Southwest China
    Northeast China
    North China
    Central China
    Northwest China

    China Finasteride market competition by top manufacturers/players, with Finasteride sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Merck
    Actavis
    Sandoz
    Teva Pharmaceuticals
    Cipla
    RelonChem
    Dr. Reddy
    Accord Pharmaceuticals
    Henan Topfond
    Zhejiang CONBA Pharmaceutical
    Shandong Renhetang Pharmaceutical
    Guangdong Eashu Pharmacetical

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Type I
    Type II

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Finasteride for each application, including
    Benign Prostatic Hyperplasia
    Male Pattern Baldness
    Other

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now